Live IPO - Mediland Pharm Ltd.

mediland pharm.jpg

Mediland Pharm Ltd (ASX: MPH) was founded as a Sydney based family business in 2002 and has grown to become a market leading retailer servicing the Chinese inbound tourism sector in Australia. With three strategically located retail outlets in Sydney, Melbourne and Surfers Paradise, the Company’s retail experience and merchandising strategies are designed to capture a significant share of the spending of the various tour groups.

By partnering with major travel agents and wholesale tour operators who are all Chinese Government certified under the Approved Destination Status (ADS) scheme, Mediland Pharm has grown strongly over the years, consistent with the growth of inbound tourist numbers from China and increasing level of expenditure by Chinese tourists.

  • Pay by: 11 February 19

  • List Price: $0.20

  • Minimum Investment: $2,000

  • Maximum Investment: $10,000

  • Prospectus

Closed